Lucemyra (lofexidine) — United Healthcare
Mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults
Preferred products
- clonidine
Initial criteria
- For symptoms of abrupt opioid withdrawal AND
- Opioids have been discontinued AND
- One of the following: History of failure, contraindication, or intolerance to clonidine OR Lucemyra was initiated in the inpatient setting
Approval duration
14 days